Showing results (21-30 of 158) with videos related to
Sort By:
Pageof 16
Urology|March 7, 2021
Therapeutic Consequences of Omitting a Pelvic Lymph Node Dissection at Radical Prostatectomy when Grade and/or Stage IncreaseMuammer Altok, Brian F Chapin, Surena F Matin, et al.Plos One|August 9, 2021
Study protocol: One plus one can be greater than two-Ecological momentary assessment for Black prostate cancer survivors and partnersDalnim Cho, Kathrin Milbury, Yue Liao, et al.Current Opinion in Urology|November 28, 2024
Prostatectomy and other local treatments for oligometastatic prostate cancer: recent and ongoing trialsAndrew M Fang, Landan P MacDonald, Justin R Gregg, et al.BJUI Compass|April 27, 2022
Does a screening digital rectal exam provide actionable clinical utility in patients with an elevated PSA and positive MRI?Courtney M Chang, Andrew G McIntosh, Daniel D Shapiro, et al.Expert Review of Anticancer Therapy|July 13, 2002
Gene therapy for prostate cancerYehoshua Gdor, Terry L Timme, Brian J Miles, et al.Molecular and Cellular Biology|December 4, 2003
Caveolin-1 maintains activated Akt in prostate cancer cells through scaffolding domain binding site interactions with and inhibition of serine/threonine protein phosphatases PP1 and PP2ALikun Li, Cheng Hui Ren, Salahaldin A Tahir, et al.Genomics|May 23, 2006
Identification and characterization of RTVP1/GLIPR1-like genes, a novel p53 target gene clusterChengzhen Ren, Cheng-Hui Ren, Likun Li, et al.Cancer|February 16, 2005
Combined c-Myc and caveolin-1 expression in human prostate carcinoma predicts prostate carcinoma progressionGuang Yang, Terry L Timme, Anna Frolov, et al.Cancer Biology & Therapy|December 17, 2005
CDC4 gene expression as potential biomarker for targeted therapy in prostate cancerMoon S Koh, Michael Ittmann, Dov Kadmon, et al.Urology|July 19, 2021
Complications Of Peri-Operative Ureteral Catheter Placement: Experience at A Major Cancer CenterAlbert A Geskin, O Lenaine Westney, William J Graber, et al.Pageof 16